← Back to Clinical Trials
Recruiting NCT06927193

NCT06927193 Regional Analgesia at the Pediatric Emergency Department

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06927193
Status Recruiting
Phase
Sponsor Hillel Yaffe Medical Center
Condition Regional Anaesthesia
Study Type OBSERVATIONAL
Enrollment 400 participants
Start Date 2026-01-01
Primary Completion 2027-01-01

Eligibility & Interventions

Sex All sexes
Min Age N/A
Max Age 18 Years
Study Type OBSERVATIONAL
Interventions
Regional anaesthesia

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 400 participants in total. It began in 2026-01-01 with a primary completion date of 2027-01-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Approximately two years ago, ultrasound-guided regional blocks technique was introduced into routine use in the pediatric emergency department at Hillel Yaffe Medical Center. Since then, nearly 300 different blocks have been performed. Study Objective: To collect a registry database of complication rates associated with regional analgesia during routine pediatric emergency department care between 2023 and 2025.

Eligibility Criteria

Inclusion Criteria: * Children who visited the pediatric emergency department between 2023-2025 and underwent a nerve block during their visit. Exclusion Criteria: * Children who visited the emergency department but had the nerve block performed outside the emargency department setting (e.g., inpatient wards or operationg room), or if the block was performed by a physician not affiliated with the pediatric emergency department.

Contact & Investigator

Central Contact

Erez Nadir, MD

✉ erezn@hymc.gov.il

📞 +9724774379

Principal Investigator

Erez Nadir, MD

PRINCIPAL INVESTIGATOR

Hillel Yaffe Medical Center

Frequently Asked Questions

Who can join the NCT06927193 clinical trial?

This trial is open to participants of all sexes, up to 18 Years, studying Regional Anaesthesia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06927193 currently recruiting?

Yes, NCT06927193 is actively recruiting participants. Contact the research team at erezn@hymc.gov.il for enrollment information.

Where is the NCT06927193 trial being conducted?

This trial is being conducted at Hadera, Israel.

Who is sponsoring the NCT06927193 clinical trial?

NCT06927193 is sponsored by Hillel Yaffe Medical Center. The principal investigator is Erez Nadir, MD at Hillel Yaffe Medical Center. The trial plans to enroll 400 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology